HOME >> MEDICINE >> NEWS
Landmark trial shows carotid stenting beneficial for patients with disease but no symptoms

Results from the largest-ever multi-center U.S. registry on the efficacy of carotid stenting shows that the procedure is safe in patients who are at high risk for standard surgical therapy.

The registry, an FDA-required post-approval study, known as CAPTURE (Carotid ACCULINK/ACCUNET Post Approval Trial to Uncover Rare Events) was presented today at the American College of Cardiology's 55th Annual Session in Atlanta. The multi-center study was led by Columbia University Medical Center researchers at NewYork-Presbyterian Hospital/Columbia.

Patients with carotid artery blockage have an increased risk of stroke, even if they experience none of the disease's symptoms, which can include weakness, paralysis, visual problems or speech difficulties. The risk of stroke over five years in asymptomatic patients is about one in eight if carotid artery disease is treated only with medical therapy. The Center for Medicare and Medicaid Services currently does not cover carotid stenting for these asymptomatic patients, so many turn to surgery to clear blocked arteries. However, some patients are ineligible for surgery because of other medical conditions.

In CAPTURE, the researchers collected data on 2,500 patients at increased risk for surgery. They were treated by 240 interventionalists at 188 medical centers across the country. All patients received Guidant's FDA-approved RX ACCULINK Carotid Stent System with RX ACCUNET Embolic Protection System. Neurologists otherwise unaffiliated with the study also evaluated patients immediately before and after stenting, and again 30 days later to judge the outcomes of the procedure.

Among asymptomatic patients, the trial found that the rate of major complications (death, stroke or heart attack) within 30 days of the stenting procedure was 5.7 percent, which is lower than the rate found in other studies of similar patients who undergo surgery.

"The scope of this landmark trial provides us with a clear
'"/>

Contact: Craig LeMoult
cel2113@columbia.edu
212-305-0820
Columbia University Medical Center
14-Mar-2006


Page: 1 2 3

Related medicine news :

1. Landmark study finds adult Delawareans with disabilities in only fair to poor health
2. Landmark schizophrenia treatment study reveals that medication alone is not always effective
3. Landmark study of islet transplantation reveals potential benefits in uncontrolled type 1 diabetes
4. Landmark study on diabetic foot infection published
5. Landmark book commemorates centennial of discovery of Alzheimers disease
6. Landmark discovery of a Kaposis sarcoma-associated herpesvirus receptor
7. Landmark hypertension study launches extensive physician and patient education program
8. New contracts support clinical trials on antibiotic-resistant, community-acquired staph infections
9. Warfarin better than aspirin at stroke prevention in elderly people with atrial fibrillation
10. Helicopter flight trials for EGNOS
11. Stroke in nonvascular atrial fibrillation -- anti-coagulants better than anti-platelet therapy

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/31/2020)... (PRWEB) , ... August 31, 2020 , ... ... of innovative higher-learning opportunities through high-quality, career-relevant, and affordable online education – is ... Psychology . , Among the first of its kind in the nation, ...
(Date:8/31/2020)... ... 31, 2020 , ... The pandemic and topsy-turvy economic outlook continues to put financial strain on ... ways to trim the fat from our monthly expenses and put more into savings, if ... that you have a financial safety net in place in case something were to happen ...
(Date:8/31/2020)... ... ... In an effort to give back to the community in which it ... room booked with a special new rate code to benefit children and families at ... Donations will be applied to any room type, any time, now through the ...
(Date:8/31/2020)... ... 31, 2020 , ... Bonde Innovations, LLC, a venture-backed developer ... failure, today announced that the company has been awarded a Phase 1 Small ... Heart, Lung, and Blood Institute of the National Institutes of Health (NIH). The ...
(Date:8/28/2020)... ... August 28, 2020 , ... Ernst & Young LLP (EY ... Entrepreneur Of The Year® 2020 Florida Award finalist. Now in its 34th year, ... innovation, growth and prosperity as they build and sustain successful businesses that transform ...
Breaking Medicine News(10 mins):
(Date:8/27/2020)... ... August 27, 2020 , ... Trella Health, the ... leading provider of cloud CRM, marketing automation, and contact center solutions for senior ... the integration of Trella’s performance intelligence data and insights into Enquire’s CRM solution ...
(Date:8/26/2020)... Mo. (PRWEB) , ... August ... ... a member of Eurofins BioPharma Services, Laboratory Testing division, expands its technology ... existing suite of Flow Cytometry platforms available. With industry-leading biomarker solutions, complemented ...
(Date:8/26/2020)... ... August 26, 2020 , ... Hero Life Sciences ... goal of 115 million 3 ply surgical disposable face masks and N95 respirators in ... direct response to the challenge that most Americans are facing in trying to find ...
Breaking Medicine Technology:
Cached News: